Ignite
Ignite, licence 80087097: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Proline Nutrition
- NPN or DIN-HM
- 80087097
- Status
- Inactive licence
- Licence date
- 16 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dendrobium nobile Source : Tige | 40.0 milligramme | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 100.0 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 5.0:1.0 Dry plant equivalent : 500.0 milligramme Potency : 45.0 % Epigallocatechin 3-gallate | 100.0 milligramme | Not calculated |
| Irvingia gabonensis Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 1000.0 milligramme | 100.0 milligramme | Not calculated |
| 3,7-diméthylxanthine Source : Théobromine | 115.0 milligramme | Not calculated |
| Indolo(2',3':3,4)pyrido(2,1-b)quinazoléin-5(7H)-one, 8,13,13b,14-tétrahydro-14-méthyl-, (13bS)- Source : Evodiamine | 5.0 milligramme | Not calculated |
| Rhodiola rosea Source : Racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 350.0 milligramme Potency : 3.0 % Rosavins | 35.0 milligramme | Not calculated |
| Plectranthus barbatus Source : Racine | 30.0 milligramme | Not calculated |
| Ilex paraguariensis Source : Feuille Potency : 1.0 % Caffeine | 30.0 milligramme | Not calculated |
| Panax ginseng Source : Racine Potency : 10.0 % Total ginsenosides | 100.0 milligramme | Not calculated |
| Piper nigrum Source : Fruit Extract : Matériel brut sec Extraction ratio : 50.0:1.0 Dry plant equivalent : 250.0 milligramme | 5.0 milligramme | Not calculated |
| Cinnamomum verum Source : Écorce (branche) | 100.0 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Potency : 3.0 % Caffeine | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Workout supplement. Athletic support.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes, iron deficiency, a liver disorder, high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome) or are taking hormone replacement therapy (HRT) or birth control pills. Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner if you are of childbearing age or breastfeeding. Hypersensitivity/allergy is known to occur, in which case, discontinue use. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, spasm and irregular heartbeat even in healthy individuals. If these symptoms occur, discontinue use and consult a health care practitioner Stop use and consult a health care practitioner if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite. Consult a health care practitioner prior to use if you are taking other natural health products or medications (including but not limited to antidepressants, blood thinners or digoxin) as black pepper/piperine may alter their effectiveness.
Source
Official Health Canada record, licence 80087097
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.